In a recent biosimilars-themed issue of The Report, the New York Intellectual Property Law Association (NYIPLA) published our article on some of the potential product liability issues that biosimilar manufacturers may have to consider in the coming years, as more biosimilars hit the U.S. market. Click here to read a…
